Analysts expect Nuvation Bio Inc. to report revenue of 33.86 M for Q3 26, against a range of 30.65 M to 37.07 M. The most recent reported quarter, Q2 26, came in at 31.69 M, a 23.3% beat against the 25.70 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 727,000.00 | 5.71 M | 3.08 M | 4.83 M | 13.12 M | 41.87 M | 83.23 M | 31.69 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 515,192.30 | 448,674.22 | 7.63 M | 38.64 M | 64.31 M | 27.13 M | 37.07 M | 50.55 M | 61.12 M | 68.38 M | 66.06 M | 77.45 M | 102.02 M | 107.01 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 427,622.70 | 409,899.32 | 6.46 M | 32.01 M | 59.46 M | 24.28 M | 30.65 M | 47.08 M | 55.60 M | 61.53 M | 58.64 M | 71.13 M | 95.60 M | 92.91 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 471,407.50 | 429,286.77 | 7.04 M | 35.32 M | 61.88 M | 25.70 M | 33.86 M | 48.82 M | 58.36 M | 64.95 M | 62.35 M | 74.29 M | 98.81 M | 99.96 M |
Analysts expect Nuvation Bio Inc. to report earnings per share of -0.12 for Q3 26, against a range of -0.13 to -0.11. The most recent reported quarter, Q2 26, came in at -0.18, a 28.6% miss against the -0.14 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.15 | -0.15 | -0.16 | -0.17 | -0.16 | -0.11 | 0.01 | -0.18 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.12 | -0.12 | -0.15 | -0.15 | -0.17 | -0.09 | -0.03 | -0.14 | -0.11 | -0.09 | -0.04 | -0.05 | -0.06 | -0.06 | 0.02 | -0.01 | ||||||||||
| Low Estimate | -0.14 | -0.14 | -0.17 | -0.17 | -0.19 | -0.11 | -0.03 | -0.14 | -0.13 | -0.11 | -0.04 | -0.05 | -0.06 | -0.06 | 0.02 | -0.01 | ||||||||||
| Consensus Estimate | -0.13 | -0.13 | -0.16 | -0.16 | -0.18 | -0.10 | -0.03 | -0.14 | -0.12 | -0.10 | -0.04 | -0.05 | -0.06 | -0.06 | 0.02 | -0.01 |
Pull Wall Street consensus for Nuvation Bio Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NUVB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NUVB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NUVB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();